Pharmacopsychiatry

14 papers5 directions
Pharmacopsychiatry is a research venue that focuses on the intersection of pharmacology, psychiatry, and biological markers, with a publication history spanning from 1986 to 2025. In the context of machine learning and artificial intelligence, the venue serves as a platform for applying computational techniques to clinical and molecular data. Research often explores the use of electronic health records and artificial intelligence to stratify patient risks, such as the likelihood of requiring coercive measures in psychiatric care. The venue publishes work on the application of reinforcement learning to understand addiction and the development of model networks to simulate gating deficits in schizophrenia. A significant portion of its computational research involves predicting treatment responses and antipsychotic effectiveness through biomarkers. This includes studies on genome-wide associations and the epigenetic programming of innate immune memory, specifically focusing on DNA methylation patterns in major depressive disorder and electroconvulsive therapy. Methodologically, the venue features research utilizing mixed effects models for longitudinal and nested data, as well as targeted gene silencing techniques. Prolific contributors to this field at Pharmacopsychiatry include Tilo Kircher, Helge Frieling, and Alexandra Neyazi. By integrating systemic biomarker analysis with predictive modeling, the venue contributes to the development of personalized psychiatric treatment strategies and the identification of clinical subtypes for psychosis and depression.

Papers by Year

2025 2
2023 1
2022 1
2020 1
2015 1
2009 1
2007 2
2006 2
2004 2
1986 1

Top Research Directions

Research directions most represented by papers from this venue.

Epigenetic and Metabolic Memory of Cellular Stress 1
Linear Mixed Effects Models for Longitudinal Data 1
Tissue Specific Divergence in Peripheral Biomarkers 1
Epigenetic and Epitranscriptomic Biomarkers for Clinical Prognosis 1
Mapping DNA Methylation Patterns to Detect Epigenetic Silencing 1

Top Authors

AuthorPapers
Franziska Eberle2
N. Jon Shah2
Chunbo Li1
Daniel Durstewitz1
Ilya Lipkovich1
Peter Dayan1

Impactful Papers

Papers from this venue that shaped research clusters.

Influential

Papers

TitleYear
A genome-wide association study of brain function across multiple cognitive domains2025
Stratifizierung des Risikos für die Anwendung von Zwangsmaßnahmen mit Hilfe von künstlicher Intelligenz und elektronischen Gesundheitsdaten2025
DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy2023
POMC and NR3C1-1F DNA methylation in major depressive disorder and electroconvulsive therapy2022
Subtypes of Clinical High Risk for Psychosis that Predict Antipsychotic Effectiveness in Long-Term Remission2020
Quantifying Midbrain Serotonin Transporter in Depression: A Preliminary Study of Diagnosis and Naturalistic Treatment Outcome2015
Dopamine, Reinforcement Learning, and Addiction2009
Do lithium levels to prevent depressive episodes differ from those to prevent manic/mixed episodes in bipolar disorder? A post-hoc analysis2007
Gating Deficits in Model Networks: A Path to Schizophrenia?2007
A Few Important Points about Dopamine’s Role in Neural Network Dynamics2006
Putting the Computation Back into Computational Modeling2006
Alcohol-craving: Therapeutic effects using fMRI2004
A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients2004
In Vivo and in Vitro Characterization of Dopamine Receptors in Hippocampus and their Pharmacological Relevance1986